Sernova Corp T.SVA

Alternate Symbol(s): SEOVF

Healthcare Biotechnology

Sernova Corp. is a Canada-based clinical-stage biotechnology company, which is developing therapeutic cell technologies for chronic diseases, including insulin-dependent diabetes, thyroid disease, and blood disorders that include hemophilia A. The Company is focused on developing a functional cure for insulin-dependent diabetes with its therapeutic cell technology, the Cell Pouch System, a novel implantable and scalable medical device with immune protected therapeutic cells. The Cell Pouch is a scalable, implantable medical device. The Cell Pouch is designed to create a vascularized organ-like environment for the transplantation and engraftment of therapeutic cells. Its regenerative medicine therapeutic approach is to provide cell therapies where the cells, transplanted within an organ-like vascularized implantable device, the Cell Pouch, generates proteins, hormones or factors released into the bloodstream for treatment of diseases requiring replacement of these molecules in the body.

TSX:SVA - Post by User

Sernova Corp > Media coverage

<< Previous

Bullboard Posts

Next >>

Comment by TotalCorruptionon Jan 18, 2021 8:43pm

347 Views

Post# 32323380

RE:RE:Media coverage

I'm confused rixpix? You've accumulated all you want. But don't want the media to promote nor let the message out? That makes zero sense. What do you want? The share price to remain at what it is? Strange. Get the damn story out.

<< Previous

Bullboard Posts

Next >>

How to navigate the ups and downs of investing in AI